Bone marrow transplantation, especially with autologous haemopoietic stem cells, is increasingly being discussed as a treatment for severe life or organ threatening autoimmune diseases.' In this context we describe a case so treated.
A 47 year old female was referred to our hospital for assessment of increasing chronic cough over three years, associated with NYHA (New York Heart Association) grade II dyspnoea and Raynaud syndrome. She complained of symptoms compatible with reflux oesophagitis but no true dysphagia. Barium swallow was normal. There were no skin changes proximal to the fingers and no telangiectasia. Capillary microscopy showed changes seen with systemic sclerosis. Antinuclear antibodies were positive at 1:640 with a centromere pattern, and the anticentromere antibody was also positive by EUSA to a titre of 1/10 240. Other autoantibodies, including anticardiolipin, were negative, as was the lupus inhibitor test. The hepatic enzymes were raised less than threefold of normal. Tests for antibodies to hepatitis A, B, and C, and smooth muscle and mitochondrial antibodies were negative.
Pulmonary assessment showed a normal x ray and high resolution computerised tomography scan of the lungs, normal lung volumes, and a slightly reduced diffusion capacity (69% ofpredicted). Bronchoalveolar lavage revealed normal total cell count but lymphocytosis of 32% (CD4/CD8 3.5). Maximum oxygen uptake was reduced to 72% predicted values (N02max 20.6 ml kg-' min-') on exercise testing. Doppler echo showed estimated systolic pulmonary artery pressure (sPAP) of 28 mm Hg, suggesting pulmonary hypertension. Treatment with 0.5 mg kg-' prednisolone was given over eight weeks with some improvement of cough and exercise induced hypoxaemia, but it was withdrawn because of side effects. Further management consisted of felodipine (5-10 mg) and omeprazole 20 mg with reasonable control for the next nine months, when a recurring cough and increasing dyspnoea (NYHA grade III) prompted re-evaluation. At this time pulmonary hypertension, with estimated systolic pulmonary artery pressure (PAP) 60 mm Hg and signs of tricuspid incompetence, was observed. VO2max had fallen to 31% predicted (8.9 ml min-' kg-'). Otherwise the clinical and laboratory observations were unchanged. Prednisone 40 mg was resumed with the addition of anticoagulants, digitalis, and diuretics without significant improvement. Therefore three pulses of 750 mg cyclophosphamide intravenously were given at monthly intervals. Because of the unchanged clinical condition vasodilator treatment was evaluated. A Swan-Ganz catheter showed a mean PAP of 45 to 50 mm Hg, with an improvement of more than 20% in PAP and pulmonary vascular resistance with a prostacyclin infusion. Oral administration of nifedipineretard 120 mg/d induced similar results. Prednisone was reduced to 10 mg/d and vasodilator treatment with nifedipine continued. After eight weeks of subjective improvement the patient deteriorated further with signs of right heart failure, angina pectoris, and electrocardiographic evidence of right heart strain. In addition, an exudative pleural effusion and polyarthralgia developed. Despite short term symptomatic improvement with increased corticosteroids, addition of nitrates (2 x 40 mg), and increased diuresis, the situation was considered critical and lung transplantation discussed. On the grounds of the systemic disease this approach was refused and immunoablation with autologous stem cell rescue was undertaken after ethics committee approval and informed consent.
Priming was induced with 2 x 3300 mg of cyclophosphamide followed by granulocyte colony stimulating factor (G-CSF; 600 jig daily subcutaneously). Haemopoietic stem cells were harvested from the peripheral blood 12 days later. Two units of blood had to be given because of anaemia. Labial herpes simplex infection was treated with acyclovir. Anticoagulation with dicoumarol was replaced by heparin injection. The harvested total nucleated cell count was 34.6 x 109 consisting of 10.4% CD 34 positive cells. After positive selection for CD34 (Ceprate) the cell count was 1.8 x 109. T and B cell depletion was achieved with combined anti-CD2/CD3 (Dako) and anti-CD19/CD20 (Baxter) antibodies using a Maxsep selection device yielding an end product of 11.5 x 106 kg-1 body weight and a total of 10.1 x 106 kg-1 body weight of CD34 cells. Ten days later conditioning was performed with 50 mg kg-' cyclophosphamide given each day for four days followed by infusion of 10.1 x 106 kg' T and B cell purged autologous stem cells. GCSF (four doses of 300 Ig; five doses of 480 jig) was administered for a total of nine days to shorten the duration of aplasia, such that the leucocyte count increased above 1 x 109/litre-' 19 days after stem cell transplantation and was normal one day later. Complications included a hypotonic collapse on day 6, cholecystitis on day 9, and right side pleural effusion on day 14. Antibiotics (amikacin, ceftazidime) were given on day 5 because of low grade fever during aplasia. Because the systemic blood pressure was lower than usual, nifedipine was stopped for one day, during which time she suffered a cardiovascular collapse (day 6). Mean PAP was 55 mm Hg (systolic 86 mm Hg; diastolic 41 mm Hg), pulmonary vascular resistance 1046 dyn s cm-5 (normal 200), and the cardiac index 1.92 litres minss m-2. With readministration of nifedipine and 500 ml 0.9 % NaCl, mPAP and resistance dropped by 15-25%, suggesting that a reversible component of pulmonary hypertension was still present. On day 15 urgent cholecystectomy was performed because of cholecystitis associated with abdominal pain and markedly raised liver enzymes not resolving with conservative treatment. The postoperative course was uneventful apart from aspiration of 1200 ml of pleural effusion and the need for increased doses of diuretics. The patient was discharged from the transplant unit 22 days following stem cell transplantation and eight days after cholecystectomy.
There have been several reports of patients with autoimmune disease who underwent allogenic and autologous bone marrow transplantation for concomitant haematological diseases. Autologous stem cell transplantation or rescue allows more intensive immunoablation and is therefore being discussed as a treatment strategy for severe autoimmune diseases which do not respond to conventional treatment. 4 5 This is the first case of a CREST-like syndrome undergoing such treatment due to otherwise uncontrollable pulmonary hypertension.
Harvesting of stem cells was uncomplicated, yielding a large number of CD34-positive cells despite previous treatment with cyclophosphamide. T and B cell purging was performed because an altered immune mechanism is likely to be relevant in the pathophysiology of autoimmune diseases. Immunoablation was well tolerated by the patient. Management of fluid balance and vasodilators was difficult because of severe pulmonary hypertension, and when infection complicated agranulocytosis. However, the patient recovered uneventfully.
Although, it is too early to determine if there will be long term benefit from this treatment, the patient noticed a significant subjective improvement of effort tolerance in the first two months after bone marrow transplantation and the angina disappeared. In the eighth post-transplant week a viral respiratory infection (cytomegalovirus negative) developed, with high fever (39.5°C) which resolved without antibiotics. One week later the patient suffered a pulmonary embolus with dyspnoea grade 4 The diagnosis of fibromyalgia was based on the criteria suggested in 1990 by the American College of Rheumatology5, that is, widespread pain and the presence of tenderness in at least 11 of 18 sites (tender points).
The diagnosis of carpal tunnel syndrome was made on clinical grounds. It included (a) history of numbness, paraesthesia, and/or pain in the fingers innervated by the median nerve, and (b) positive Tinel sign or positive Phalen sign. Invasive tests, such as nerve conduction studies, were not performed in view of the epidemiological nature of the research.
After two mailings, 2440 out of 4456 subjects (54.8%) returned the questionnaire. Of these, 182 (7.5%) had joint pain and swelling in at least two joints. This group of patients was offered a clinical examination; 93 (51.1%) agreed to be visited. Fibromyalgia was present in 21 (22.6%) of these patients and carpal tunnel syndrome in 26 (28%). Both conditions occurred simultaneously in nine patients (9.7%) (table). The odds ratio for patients with any one of the conditions of showing the other one was 2.4 (95% confidence interval 0.9 to 6.8). These fibromyalgia-carpal tunnel syndrome patients were all female, whereas 23.5% of patients with carpal tunnel syndrome were male. What is more, if only women with carpal tunnel syndrome or fibromyalgia are considered, nearly half of them also had the other disease. The mean number of tender points was obviously higher in patients with fibromyalgia than in those with carpal tunnel syndrome alone (13.2 v 3.8; P < 0.001). Self reported joint swelling and early morning stiffness were similarly distributed in the three groups of patients.
Our data show that responders who reported a history of joint pain and swelling of peripheral joints were often affected by fibromyalgia or carpal tunnel syndrome. This study does not disclose the absolute prevalence of fibromyalgia and carpal tunnel syndrome because the questionnaire was intended for screening patients with possible rheumatoid arthritis and not those with fibromyalgia or carpal tunnel syndrome. However, in a pilot study, most of the outpatients with these conditions attending a rheumatological clinic answered positively to the questionnaire. We believe that patients with fibromyalgia reported articular involvement on the mannequin because they were unable to differentiate articular from extra-articular pain. In addition, they frequently overreported swelling. Patients with carpal tunnel syndrome as a rule complain of pain and numbness associated with a subjective sensation of swelling in the hands, especially in the morning. Both fibromyalgia and carpal tunnel syndrome are characterised by morning stiffness.
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